Spot Trading’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$6.55M Sell
46,700
-29,200
-38% -$3.97M 0.84% 194
2017
Q2
$9.23M Buy
75,900
+69,700
+1,124% +$8.11M 1.37% 92
2017
Q1
$752K Sell
6,200
-45,300
-88% -$5.84M 0.21% 943
2016
Q4
$6.3M Buy
51,500
+48,800
+1,807% +$5.97M 1.03% 154
2016
Q3
$331K Sell
2,700
-70,300
-96% -$9.05M 0.05% 1765
2016
Q2
$8.52M Sell
73,000
-9,100
-11% -$1.29M 1.16% 145
2016
Q1
$11.4M Buy
82,100
+68,500
+504% +$10.1M 1.5% 95
2015
Q4
$2.59M Buy
13,600
+4,800
+55% +$838K 0.19% 839
2015
Q3
$1.38M Sell
8,800
-5,700
-39% -$1.04M 0.09% 1341
2015
Q2
$2.62M Buy
14,500
+9,800
+209% +$1.69M 0.16% 972
2015
Q1
$815K Sell
4,700
-6,800
-59% -$1.23M 0.05% 1755
2014
Q4
$2.13M Sell
11,500
-100
-0.9% -$18.5K 0.1% 1354
2014
Q3
$1.92M Buy
11,600
+300
+3% +$49.3K 0.07% 1582
2014
Q2
$1.77M Buy
11,300
+2,400
+27% +$379K 0.06% 1740
2014
Q1
$1.35M Sell
8,900
-7,200
-45% -$1.14M 0.05% 1812
2013
Q4
$2.14M Sell
16,100
-21,000
-57% -$2.52M 0.08% 1460
2013
Q3
$4.31M Buy
37,100
+22,100
+147% +$2.42M 0.22% 825
2013
Q2
$1.38M Buy
+15,000
New +$1.45M 0.07% 1664

Other funds holding ALXN